A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension

Hemnes, Anna R.; Silverman-Lloyd, Luke G; Huang, Shi; MacKinnon, Grant E.; Annis, Jeffrey; Whitmore, Carolyn S.; Mallugari, Ravinder; Oggs, Rashundra N.; Hekmat, Rezzan; Shan, Rongzi; Huynh, Pauline P.; Yu, Chang; Martin, Seth S.; Blaha, Michael J.; Brittain, Evan L.

doi:10.1016/j.chest.2021.04.012

Cited by 22 publications

(17 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 37 The fact that TRACE patients were not encouraged to increase their activity may have contributed to the limited changes to DLPA parameters. Indeed, home-based intervention programs for patients with PAH can result in an increased intensity of DLPA, 38 which should be considered in future trials in which DLPA is measured to evaluate a treatment effect. Common barriers to physical activity reported by patients with PAH include “lack of energy, lack of self-discipline, and lack of interest” in exercise, 39 and interventions to address these barriers could also be considered in future trials.…”

Section: Discussionmentioning

confidence: 99%

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension

Howard¹,

Rosenkranz²,

Frantz³

et al. 2023

CHEST

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension

Howard¹,

Rosenkranz²,

Frantz³

et al. 2023

CHEST

Self Cite

View full text Add to dashboard Cite

“…Stable PAH patients should be encouraged to be active. It has been demonstrated that patients who keep performing their daily activities or increase their level of physical activity improve their distance in 6MWD compared to sedentary patients [ 28 ]. The I-Jet infusion pump helped PAH patients to comfortably carry out their daily activities.…”

Section: Discussionmentioning

confidence: 99%

Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension

Waligóra

Żuławińska

Tomaszewski

et al. 2023

JPM

View full text Add to dashboard Cite

Background and Objectives: Parenteral prostacyclins are crucial in the pharmacological treatment of pulmonary arterial hypertension (PAH). Indeed, subcutaneous administration of treprostinil has been associated with considerable clinical and hemodynamic improvement, right-sided heart reverse remodeling, and long-term survival benefit. However, evidence on patient perceptions about handling a subcutaneous infusion pump for self-treatment administration and nurse views about training the patients are lacking. This study aimed to describe the perception of PAH patients and nurses regarding the use of the new portable I-Jet infusion pump for the self-administration of subcutaneous treprostinil, as well as its real-world training needs. Materials and Methods: The study is an open, observational, prospective, single-center, non-interventional study. Patients with PAH on stable therapy with subcutaneous treprostinil were invited to take part in the study at their start of use of the portable I-Jet infusion pump for the self-administration of treatment. Participants filled in a questionnaire to report their satisfaction with the use of the pump, as well as their compliance, confidence, convenience, preferences, technical issues, and perceptions of the training they received. Results: Thirteen patients completed the questionnaire after being on the pump for 2 months: 69% were females and the mean age was 51 years. The most frequent PAH etiologies were congenital heart disease (46.2%) and idiopathic PAH (38.4%). Most patients were either World Health Organization (WHO) functional class II (53.8%) or III (46.2%). Ten patients (76.9%) found the pump easy and convenient to live with. All patients declared themselves to be fully compliant and confident in using the pump (n = 13) at the end of the study follow-up. Ten patients (76.9%) would choose the new pump in the future. None of the patients made reference to technical issues that required additional hospital visits. Eight patients (61.6%) reported that learning how to use the I-Jet infusion pump was easy or very easy, and none considered that further training was needed. One trainer nurse was interviewed and confirmed the satisfaction of patients and the simplicity of usage and training. Conclusions: PAH patients were highly satisfied with the use of the new portable I-Jet infusion pump for self-administering subcutaneous treprostinil. Convenience and ease of use were valuable and commonly reported features. Moreover, the training requirement was simple. These preliminary findings support the routine use of the I-Jet infusion pump.

show abstract

“…57 A similar study design led to an increase of >1000 steps per day and improved the quality of life in a population with pulmonary artery hypertension. 58 Gamification integrates elements such as points or achievements to promote competition and facilitate positive lifestyle modifications. 59 For example, the Behavioral Economics Framingham Incentive Trial (BE FIT) study of 200 adults comprising 94 families used a gamification intervention focused on behavioral economics principles to increase PA. 59 Over the course of 12 weeks, the families were awarded 70 points at the start of each week.…”

Section: Physical Activitymentioning

confidence: 99%

Wearable Devices in Cardiovascular Medicine

Hughes

Shandhi

Master

et al. 2023

Circulation Research

View full text Add to dashboard Cite

Wearable devices, such as smartwatches and activity trackers, are commonly used by patients in their everyday lives to manage their health and well-being. These devices collect and analyze long-term continuous data on measures of behavioral or physiologic function, which may provide clinicians with a more comprehensive view of a patients’ health compared with the traditional sporadic measures captured by office visits and hospitalizations. Wearable devices have a wide range of potential clinical applications ranging from arrhythmia screening of high-risk individuals to remote management of chronic conditions such as heart failure or peripheral artery disease. As the use of wearable devices continues to grow, we must adopt a multifaceted approach with collaboration among all key stakeholders to effectively and safely integrate these technologies into routine clinical practice. In this Review, we summarize the features of wearable devices and associated machine learning techniques. We describe key research studies that illustrate the role of wearable devices in the screening and management of cardiovascular conditions and identify directions for future research. Last, we highlight the challenges that are currently hindering the widespread use of wearable devices in cardiovascular medicine and provide short- and long-term solutions to promote increased use of wearable devices in clinical care.

show abstract

A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension

Cited by 22 publications

References 21 publications

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension

Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension

Wearable Devices in Cardiovascular Medicine

Contact Info

Product

Resources

About